Abstract:In this study, we built classification models using machine learning techniques to predict the bioactivity of non-covalent inhibitors of Bruton's tyrosine kinase (BTK) and to provide interpretable and transparent explanations for these predictions. To achieve this, we gathered data on BTK inhibitors from the Reaxys and ChEMBL databases, removing compounds with covalent bonds and duplicates to obtain a dataset of 3895 inhibitors of non-covalent. These inhibitors were characterized using MACCS fingerprints and Morgan fingerprints, and four traditional machine learning algorithms (decision trees (DT), random forests (RF), support vector machines (SVM), and extreme gradient boosting (XGBoost)) were used to build 16 classification models. In addition, four deep learning models were developed using deep neural networks (DNN). The best model, Model D_4, which was built using XGBoost and MACCS fingerprints, achieved an accuracy of 94.1% and a Matthews correlation coefficient (MCC) of 0.75 on the test set. To provide interpretable explanations, we employed the SHAP method to decompose the predicted values into the contributions of each feature. We also used K-means dimensionality reduction and hierarchical clustering to visualize the clustering effects of molecular structures of the inhibitors. The results of this study were validated using crystal structures, and we found that the interaction between the BTK amino acid residue and the important features of clustered scaffold was consistent with the known properties of the complex crystal structures. Overall, our models demonstrated high predictive ability and a qualitative model can be converted to a quantitative model to some extent by SHAP, making them valuable for guiding the design of new BTK inhibitors with desired activity.

Using self-organizing map (SOM) and support vector machine (SVM) for classification of selectivity of ACAT inhibitors

Classification of Src Kinase Inhibitors Based on Support Vector Machine

Discovery of selective ACAT2 antagonist via a combination strategy based on deep docking, pharmacophore modelling, and molecular dynamics simulation

Classification Models for Acetylcholinesterase Inhibitors Based on Machine Learning Methods

Classification models and SAR analysis of anaplastic lymphoma kinase (ALK) inhibitors using machine learning algorithms with two data division methods

Assessment of CYP2C9 Structural Models for Site of Metabolism Prediction

Predicting Anti‐HIV‐1 Activities of HEPT‐analog Compounds by Using Support Vector Classification

Classification of 5-Ht1a Receptor Ligands on the Basis of Their Binding Affinities by Using Pso-Adaboost-Svm

Classification of substrates and inhibitors of P-glycoprotein using unsupervised machine learning approach.

Support Vector Machine (SVM) Models for Predicting Inhibitors of the 3' Processing Step of HIV-1 Integrase

Screening of Selective Histone Deacetylase Inhibitors by Proteochemometric Modeling

Classification of 5-HT(1A) Receptor Agonists and Antagonists Using GA-SVM Method.

The Computational Model to Predict Accurately Inhibitory Activity for Inhibitors Towardscyp3a4

Combinatorial Support Vector Machines Approach for Virtual Screening of Selective Multi-Target Serotonin Reuptake Inhibitors from Large Compound Libraries

Machine learning-based classification models for non-covalent Bruton's tyrosine kinase inhibitors: predictive ability and interpretability

A two-step target binding and selectivity support vector machines approach for virtual screening of dopamine receptor subtype-selective ligands.

Identifying Human SIRT1 Substrates by Integrating Heterogeneous Information from Various Sources

Accelerating the identification of subtype selective inhibitors via Three-Dimensional Biologically Relevant Spectrum (BRS-3D): The monoamine oxidase subtypes as a case study

Evaluation of Virtual Screening Performance of Support Vector Machines Trained by Sparsely Distributed Active Compounds

Virtual Screening of Selective Multitarget Kinase Inhibitors by Combinatorial Support Vector Machines

Deciphering Cathepsin K inhibitors: a combined QSAR, docking and MD simulation based machine learning approaches for drug design